Glucose tolerance status is a better predictor of diabetes and cardiovascular outcomes than metabolic syndrome: a prospective cohort study

Table 2 Laboratory characteristics of patients according to oral glucose tolerance test groups

	Normal (n = 43)	IFG^£(n = 42)	IGT^£(n = 38)	DM^£(n = 25)	p
Fasting Plasma Glucose (mg/dL)	92 ± 5*	109 ± 6	108 ± 11	123 ± 15*	0.001
2 hour Plasma Glucose (mg/dL)	96 ± 24*	117 ± 16*	161 ± 17*	239 ± 37*	<0.001
Total Cholesterol (mg/dL)	209 ± 43	218 ± 47	203 ± 33	209 ± 49	0.51
HDL- Cholesterol (mg/dL)	49 ± 11	52 ± 13	47 ± 11	46 ± 10	0.18
Triglycerides (mg/dL)	164 ± 172	151 ± 68	174 ± 99	195 ± 104	0.52
LDL- Cholesterol (mg/dL)	130 ± 35	135 ± 43	123 ± 29	124 ± 44	0.48
Creatinine (mg/dL)	0.96 ± 0.17	0.96 ± 0.24	0.94 ± 0.17	0.96 ± 0.31	0.97

Data expressed in mean ± standard deviation.
^£Oral glucose tolerance test groups: IFG impaired fasting glucose, IGT impaired glucose tolerance, DM diabetes mellitus.
*Difference between groups.

ISSN: 1758-5996